fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EHA 2018: Preferred treatment combinations and sequencing in transplant eligible and elderly MM patients

Written by | 24 Jun 2018

The growing number of novel treatments for multiple myeloma (MM) means that more patients can achieve the therapeutic goal of a deep and prolonged first remission – in… read more.

ICML 2017: The role of stem cell transplantation for lymphoma in 2017

Written by | 11 Jul 2017

By Maria Dalby (article) and Esther Drain (interviews) Even in an era of rapid progress in terms of new agents and treatment approaches, stem cell transplantation (SCT) continues… read more.

BSH 2017: Plenary debate: Allogeneic transplantation should be considered for selected young patients

Written by | 14 Apr 2017

Even in the era of novel therapies for newly-diagnosed and relapsed/refractory MM, there is a group of patients for whom the myeloma biology significantly shortens life expectancy. Allogeneic… read more.

EHA 2016: Professor Kwee Yong (London) and Dr Mark Cook (Birmingham) share EHA highlights that will affect practice in the UK, including excitement around daratumumab and where research in the molecular stratification of disease is guiding practice. Professor Sagar Lonial (Atlanta) shares his highlights of EHA and ASCO, including data confirming the benefit of maintenance therapy and of transplant, and Professor Roman Hajek (Ostrava) gives a reality check on what the new data means for patients and haematolgists.

Written by | 14 Jul 2016

ILTS 2016: Hepatocellular Carcinoma: To resect or transplant first? Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.

Written by | 15 Jun 2016

ILTS 2016: Risk of living donor transplants can be mitigated: Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada). Also included associated article.

Written by | 13 Jun 2016

Risk of living donor transplants can be mitigated by Thomas R. Collins Making living donor transplants less risky through new and innovative approaches is the best way to… read more.

ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled 'Done correctly, living donation success is possible'

Written by | 10 Jun 2016

Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled ‘Done correctly, living donation success is possible’

Written by | 10 Jun 2016

Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

ILTS 2016 Highlights: ILTS President, Professor Jan Lerut (University Hospital St Luc, Brussels, Belgium), Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea), Professor John Lake (University of Minnesota, MN, USA), Professor John O’Grady (Kings College Hospital, London) and Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada) give their highlights from this year’s ILTS in Seoul.

Written by | 9 Jun 2016

ISH/BSH 2016: Dr Craig Moskowitz (Memorial Sloan Kettering Cancer Center, NY, USA) and Professor David Linch (University College London Hospital) discuss the role of transplant in HL. Also included an associated article entitled ‘Allogeneic stem cell transplantation: still a role in CLL/lymphoma?’

Written by | 6 Jun 2016

Allogeneic stem cell transplantation: still a role in CLL/lymphoma? by Christine Clark Professor Peter Dreger, Heidelberg University Hospital, Germany. The goal of allogeneic transplant therapy is to provide… read more.

BTS 2016: Transplantation of kidneys from small paediatric donors. Can we set a limit? Niaz Ahmad, St James's Hospital, Leeds

Written by | 24 Mar 2016

by Maria Dalby:  Organ donation from children aged less than 2 years is extremely rare in the UK but could offer significant scope for expanding the donor pool…. read more.

BTS 2016: Transplantation of kidneys from small paediatric donors. Can we set a limit? Niaz Ahmad, St James’s Hospital, Leeds

Written by | 24 Mar 2016

by Maria Dalby:  Organ donation from children aged less than 2 years is extremely rare in the UK but could offer significant scope for expanding the donor pool…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.